✦ LIBER ✦

Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison

✍ Scribed by Signorovitch, James; Swallow, Elyse; Kantor, Evan; Wang, Xufang; Klimovsky, Judith; Haas, Tomas; Devine, Beth; Metrakos, Peter

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sunitinib for advanced pancreatic neuroe

✍ Hubner, Richard A ;Valle, Juan W 📂 Article 📅 2011 🏛 Expert Reviews 🌐 English ⚖ 424 KB

Everolimus: A New Treatment Option for A

✍ Thompson, L. A.; Kim, M.; Wenger, S. D.; O'Bryant, C. L. 📂 Article 📅 2012 🏛 Harvey Whitney Books Company 🌐 English ⚖ 155 KB

A prospective, phase 1/2 study of everol

✍ Chan, Jennifer A.; Blaszkowsky, Lawrence; Stuart, Keith; Zhu, Andrew X.; Allen, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

FDA Approval Summary: Sunitinib for the

✍ Blumenthal, G. M.; Cortazar, P.; Zhang, J. J.; Tang, S.; Sridhara, R.; Murgo, A. 📂 Article 📅 2012 🏛 Alphamed Press 🌐 English ⚖ 137 KB

PCN61 Cost-Effectiveness of Sunitinib +

✍ Chi-Chan, A.; Gutiérrez-Colín, C.I.; Peniche-Otero, G.; Herrera-Rojas, J.; Muciñ 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Comparison of EUS Morphology and Perform

✍ Shireen A. Pais; Mohammad A. Al-Haddad; Julia K. Leblanc; Stuart Sherman; Lee Mc 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 39 KB